These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 25035352)

  • 41. [Comparison of various cyclophosphamide treatment regimens on the course and outcome of lupus nephritis ].
    Petrović R; Stojanović R; Novicić-Sasić D; Dimitrijević J; Pavlović S; Stojković D; Palić-Obradović D; Stevanović G; Prodanović S
    Srp Arh Celok Lek; 2002 Aug; 130 Suppl 3():19-25. PubMed ID: 12583309
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dexamethasone cyclophosphamide pulse therapy in lichen amyloidosus: a case report.
    Gupta R; Gupta S
    J Dermatolog Treat; 2007; 18(4):249-51. PubMed ID: 17671886
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Dexamethasone-cyclophosphamide pulse therapy in bullous autoimmune dermatoses].
    Appelhans M; Bonsmann G; Orge C; Bröcker EB
    Hautarzt; 1993 Mar; 44(3):143-7. PubMed ID: 8463094
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pulse versus oral methylprednisolone therapy in pemphigus vulgaris.
    Shahidi-Dadras M; Karami A; Toosy P; Shafiyan A
    Arch Iran Med; 2007 Jan; 10(1):1-6. PubMed ID: 17198445
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dexamethasone pulse therapy in pemphigus.
    Tóth GG; van de Meer JB; Jonkman MF
    J Eur Acad Dermatol Venereol; 2002 Nov; 16(6):607-11. PubMed ID: 12482045
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immunoablative high-dose cyclophosphamide without stem cell rescue in a patient with pemphigus vulgaris.
    Hayag MV; Cohen JA; Kerdel FA
    J Am Acad Dermatol; 2000 Dec; 43(6):1065-9. PubMed ID: 11100024
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Treatment of pemphigus vulgaris with pulse intravenous cyclophosphamide.
    Pandya AG; Sontheimer RD
    Arch Dermatol; 1992 Dec; 128(12):1626-30. PubMed ID: 1456758
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dexamethasone cyclophosphamide pulse therapy is highly efficient in autoimmune blistering and connective tissue disorders.
    Manousaridis I; Utikal J; Goerdt S; Booken N
    Eur J Dermatol; 2011; 21(1):129-30. PubMed ID: 21224179
    [No Abstract]   [Full Text] [Related]  

  • 49. Pemphigus in India.
    Kanwar AJ; De D
    Indian J Dermatol Venereol Leprol; 2011; 77(4):439-49. PubMed ID: 21727691
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long-term prognosis of pemphigus in central Kerala, India: a retrospective cohort study.
    Ajithkumar K
    Indian J Dermatol Venereol Leprol; 2014; 80(1):64-5. PubMed ID: 24448129
    [No Abstract]   [Full Text] [Related]  

  • 51. Short-term Intensive Immunosuppression: A Randomized, Three-arm Study of Intravenous Pulse Methylprednisolone and Cyclophosphamide in Macular Serpiginous Choroiditis.
    Venkatesh P; Tayade A; Gogia V; Gupta S; Shah BM; Vohra R
    Ocul Immunol Inflamm; 2018; 26(3):469-476. PubMed ID: 27849419
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pulse intravenous cyclophosphamide therapy in pemphigus.
    Fleischli ME; Valek RH; Pandya AG
    Arch Dermatol; 1999 Jan; 135(1):57-61. PubMed ID: 9923782
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cyclophosphamide-Induced Hearing Loss: Reversibility and Preventive Strategies.
    Tuknayat A; Thami GP; Gogia P; Bhutani M
    Am J Ther; 2018; 25(6):e692-e695. PubMed ID: 29232285
    [No Abstract]   [Full Text] [Related]  

  • 54. Repeated pulse of methylprednisolone and cyclophosphamide with continuous dexamethasone therapy for patients with severe paraquat poisoning.
    Lin JL; Lin-Tan DT; Chen KH; Huang WH
    Crit Care Med; 2006 Feb; 34(2):368-73. PubMed ID: 16424716
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Improved survival in severe paraquat poisoning with repeated pulse therapy of cyclophosphamide and steroids.
    Lin JL; Lin-Tan DT; Chen KH; Huang WH; Hsu CW; Hsu HH; Yen TH
    Intensive Care Med; 2011 Jun; 37(6):1006-13. PubMed ID: 21327593
    [TBL] [Abstract][Full Text] [Related]  

  • 56. High dose oral prednisone vs. prednisone plus azathioprine for the treatment of oral pemphigus: a retrospective, bi-centre, comparative study.
    Chaidemenos G; Apalla Z; Koussidou T; Papagarifallou I; Ioannides D
    J Eur Acad Dermatol Venereol; 2011 Feb; 25(2):206-10. PubMed ID: 20569289
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The adjuvant therapy of pemphigus. An update.
    Bystryn JC; Steinman NM
    Arch Dermatol; 1996 Feb; 132(2):203-12. PubMed ID: 8629830
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Peculiar pattern of nail pigmentation following cyclophosphamide therapy.
    Dave S; Thappa DM
    Dermatol Online J; 2003 Aug; 9(3):14. PubMed ID: 12952761
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Urocytological evaluation of pemphigus patients on long term cyclophosphamide therapy: A cross sectional study.
    Khandpur S; Singh S; Mallick S; Sharma VK; Iyer V; Seth A; Kumawat M
    Indian J Dermatol Venereol Leprol; 2017; 83(6):667-672. PubMed ID: 29035286
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Factors Affecting the Duration of Phase 1 of Dexamethasone-Immunosuppressant Pulse Therapy for Pemphigus Group of Disorders: A 10-Year Retrospective Study in a Tertiary Care Center.
    Mundakkat V; Sridharan R
    Indian Dermatol Online J; 2018; 9(6):405-408. PubMed ID: 30505779
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.